Cargando…

Thrombopoietin as Biomarker and Mediator of Cardiovascular Damage in Critical Diseases

Thrombopoietin (TPO) is a humoral growth factor originally identified for its ability to stimulate the proliferation and differentiation of megakaryocytes. In addition to its actions on thrombopoiesis, TPO directly modulates the homeostatic potential of mature platelets by influencing their response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lupia, Enrico, Goffi, Alberto, Bosco, Ornella, Montrucchio, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337636/ https://www.ncbi.nlm.nih.gov/pubmed/22577249 http://dx.doi.org/10.1155/2012/390892

Ejemplares similares

Blockade of Thrombopoietin Reduces Organ Damage in Experimental Endotoxemia and Polymicrobial Sepsis
por: Cuccurullo, Alessandra, et al.
Publicado: (2016)

Thrombopoietin Contributes to Enhanced Platelet Activation in Patients with Type 1 Diabetes Mellitus
por: Bosco, Ornella, et al.
Publicado: (2021)

Thrombopoietin participates in platelet activation in COVID-19 patients
por: Lupia, Enrico, et al.
Publicado: (2022)

Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: Vizio, Barbara, et al.
Publicado: (2021)

Platelets and Multi-Organ Failure in Sepsis
por: Greco, Elisabetta, et al.
Publicado: (2017)

Increased plasma levels of thrombopoietin in patients with severe acute pancreatitis
por: Pigozzi, L, et al.
Publicado: (2013)

Involvement of thrombopoietin in the development of organ injury in a mouse model of cecal ligation and puncture-induced sepsis
por: Greco, E, et al.
Publicado: (2012)

Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation
por: Schiavello, Martina, et al.
Publicado: (2023)

Thrombopoietin may enhance ventilator-induced lung injury
por: Del Sorbo, LD, et al.
Publicado: (2011)

Cardiovascular Hypertension-Mediated Organ Damage in Hypertensive Urgencies and Hypertensive Outpatients
por: Vallelonga, Fabrizio, et al.
Publicado: (2022)

Thrombopoietin protects hematopoietic stem cells from retrotransposon-mediated damage by promoting an antiviral response
por: Barbieri, Daniela, et al.
Publicado: (2018)

In and out: Traffic and dynamics of thrombopoietin receptor
por: Roy, Anita, et al.
Publicado: (2021)

Thrombopoietin and its receptor in normal and neoplastic hematopoiesis
por: Kaushansky, Kenneth
Publicado: (2016)

Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia
por: Bastida, José María, et al.
Publicado: (2021)

Thrombopoietin receptor agonists: ten years later
por: Ghanima, Waleed, et al.
Publicado: (2019)

Overproduction of thrombopoietin by BRAFV600E‐mutated mouse hepatocytes and contribution of thrombopoietin to hepatocarcinogenesis
por: Tanaka, Hiroki, et al.
Publicado: (2019)

Mechanism of mutant calreticulin-mediated activation of the thrombopoietin receptor in cancers
por: Venkatesan, Arunkumar, et al.
Publicado: (2021)

Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2019)

Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists
por: Nilles, Kathy M., et al.
Publicado: (2019)

Thrombopoietin: tickling the HSC's fancy
por: Kim, Ah Ram, et al.
Publicado: (2017)

Icaritin Provokes Serum Thrombopoietin and Downregulates Thrombopoietin/MPL of the Bone Marrow in a Mouse Model of Immune Thrombocytopenia
por: Zhang, Ke, et al.
Publicado: (2018)

The thrombopoietin receptor: revisiting the master regulator of platelet production
por: Hitchcock, Ian S., et al.
Publicado: (2021)

The Thrombopoietin Receptor Can Mediate Proliferation without Activation of the Jak-STAT Pathway
por: Dorsch, Marion, et al.
Publicado: (1997)

A review of immune thrombocytopenic purpura: focus on the novel thrombopoietin agonists
por: Khan, Meaghan, et al.
Publicado: (2010)

DNA Repair and Cytokines: TGF-β, IL-6, and Thrombopoietin as Different Biomarkers of Radioresistance
por: Centurione, Lucia, et al.
Publicado: (2016)

Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia
por: González-Porras, José R., et al.
Publicado: (2019)

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
por: Nakai, Kensaku, et al.
Publicado: (2022)

Critical roles for the phosphatidylinositide 3-kinase isoforms p110β and p110γ in thrombopoietin-mediated priming of platelet function
por: Moore, Samantha F., et al.
Publicado: (2019)

Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists
por: Gilreath, Jeffrey, et al.
Publicado: (2021)

Thrombopoietin Secretion by Human Ovarian Cancer Cells
por: Besbes, Samaher, et al.
Publicado: (2017)

The uORF-containing thrombopoietin mRNA escapes nonsense-mediated decay (NMD)
por: Stockklausner, Clemens, et al.
Publicado: (2006)

Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements
por: Montrucchio, G., et al.
Publicado: (2021)

Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review
por: Agarwal, Nikki, et al.
Publicado: (2021)

Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag
por: Abdela, Jemal
Publicado: (2019)

Clinical applications of thrombopoietin silencing: A possible therapeutic role in COVID-19?
por: Alentado, Vincent J., et al.
Publicado: (2021)

Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin
Publicado: (1996)

Altered B-lymphopoiesis in mice with deregulated thrombopoietin signaling
por: Au, Amanda E., et al.
Publicado: (2017)

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
por: Pecci, Alessandro, et al.
Publicado: (2017)

Has lung ultrasound an impact on the management of patients with acute dyspnea in the emergency department?
por: Goffi, Alberto, et al.
Publicado: (2013)

Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia
por: Garzon, Angelica Maria, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g9tli5v4ovnklql3f8022ni3qj